It looks like you have an older browser that is not supported by this site. Please click here to update.

Article Open to All

Choosing the Appropriate COVID-19 Monoclonal Antibody Therapies and Antiviral Therapeutics and Accessing the new Antiviral Medications

Posted Jan 4, 20221 min Read

Regulatory & Clinical

The Indiana Department of Health has released a new resource related to the multiple COVID-19 treatments with key recommendations for therapies including the new antiviral medications that can be taken orally at a person home. Not all treatments can be therapeutic for everyone and using the guide will help providers in identifying appropriate treatment.

The use of the new “at Home” antiviral medications have a very limited supply, and a prescription does not guarantee the medication will be available. A residents healthcare provider might recommend one of the new antiviral medications listed in the guideline to help relieve symptoms during a COVID-19 infections.  The new Guideline, a listing of Indiana locations with a limited supply of the antiviral medications and other information can be obtained at the following:

About the Author

Lori Davenport, Director of Clinical & Regulatory Affairs